2024 Annual Meeting | C182 - The New Era of Brain Health Across the Lifespan: How Science and Public Policy Can Improve Neurologic Outcomes for All

Date Wednesday 04/17/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Location Colorado Convention Center | 601

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Joel Salinas, MD, MBA, MSc, FAAN

Topic(s) General Neurology

Learning Objectives Participants should become familiar with emerging evidence-based practice for timely and appropriate intervention to reduce risks and enhance protective factors for brain health conditions; learn how to consider development and implementation of interventions and systems-based practice to improve quality of life for those affected by brain health conditions appropriate to each life epoch; and, understand approaches to collaborate across disciplines, organizations, and initiatives to best coordinate research, education, and policy efforts to advance brain health.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice, Quality Improvement

Program Level Introductory

Program Tracks Advanced Practice Provider, Brain Health

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:50 PM MDT	Speaker	Brain Health: Yesterday, Today, and Tomorrow Joel Salinas, MD, MBA, MSc, FAAN
03:50 PM - 04:15 PM MDT	Speaker	Brain Health in Early Life: The Strongest Start Ann H. Tilton, MD, FAAN
04:15 PM - 04:40 PM MDT	Speaker	Brain Health in Mid Life: Prevent & Optimize, Recover & Preserve Behnam Sabayan, MD, PhD, MSPH
04:40 PM - 05:05 PM MDT	Speaker	Brain Health in Late Life: Shining in the Platinum Years Daniel J. Correa, MD, MSc, FAAN
05:05 PM - 05:30 PM MDT	Speaker	Turning Science into Policy: AAN Leading the Charge Justin T. Jordan, MD, MPH, FAAN

Faculty Disclosures
Joel Salinas, MD, MBA, MSc, FAAN	Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai, Inc. Dr. Salinas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly, Inc. Dr. Salinas has stock in Isaac Health.
Justin T. Jordan, MD, MPH, FAAN	Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Dietitians on Demand. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Harborlight Montesorri. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Navio Theragnostics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Recursion Pharmaceuticals, Inc. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BCD Meetings. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akeila Bio. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has stock in Navio Theragnostics. Dr. Jordan has stock in The Doctor Lounge. An immediate family member of Dr. Jordan has stock in OldGate. Dr. Jordan has stock in Akeila Bio. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Reimbursement for potential consultant role that was aborted with Magnet Biomedicine. Dr. Jordan has a non-compensated relationship as a board member with United Council for Neurologic Subspecialties that is relevant to AAN interests or activities.
Ann H. Tilton, MD, FAAN	Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for allergan. Dr. Tilton has received personal compensation in the range of $0-$499 for serving as a Consultant for Medlink. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Dr. Tilton has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Keane law firm - Defense.
Behnam Sabayan, MD, PhD, MSPH	Dr. Sabayan has nothing to disclose.
Daniel J. Correa, MD, MSc, FAAN	Dr. Correa has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Correa has stock in Aidin Inc. Dr. Correa has received research support from Genentech. Dr. Correa has received research support from Psi Upsilon Foundation Inc.